A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer Meeting Abstract
| Authors: | Green, A.; Zhou, Q.; Iasonos, A.; Zammarrelli, W.; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Hom, V.; Erinjeri, J. P.; Petkovska, I.; Chandarlapaty, S.; Cohen, S. M.; Grisham, R. N.; Konner, J. A.; Rubinstein, M. M.; Tew, W. P.; Troso-Sandoval, T. A.; Aghajanian, C.; Makker, V. |
| Abstract Title: | A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401360 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.5511 |
| Notes: | Meeting Abstract: 5511 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
